Açık Akademik Arşiv Sistemi
Safely use of omalizumab during SARS-CoV-2 infection in patients with chronic spontaneous urticaria
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.date.accessioned | 2023-03-06T07:32:38Z | |
| dc.date.available | 2023-03-06T07:32:38Z | |
| dc.date.issued | 2023 | |
| dc.identifier.citation | J Cosmet Dermatol. 2023 Jan;22(1):26-27. doi: 10.1111/jocd.15544. Epub 2022 Nov 30. | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12619/100394 | |
| dc.relation.isversionof | 10.1111/jocd.15544 | |
| dc.relation.isversionof | 10.1111/jocd.15544 | |
| dc.title | Safely use of omalizumab during SARS-CoV-2 infection in patients with chronic spontaneous urticaria | |
| dc.relation.journal | J Cosmet Dermatol | |
| dc.identifier.doi | 10.1111/jocd.15544 | |
| dc.contributor.author | Özdemir Ö | |
| dc.contributor.author | Özdemir Ö | |
| dc.contributor.author | Dikici Ü. |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
DSpace@Sakarya by Sakarya University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..
DSpace@Sakarya:
